Competitive Binding Assays Made Easy with a Native Marker and Mass Spectrometric Quantification

Angewandte Chemie - International Edition

Volumn 42, Issue 42, 2003, Pages 5235-5237

  Höfner, Georg ^a   Wanner, Klaus Theodor ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Analytical methods; Assays; Binding; Dopamine receptors; Drug screening; Mass spectrometry

Indexed keywords

BIOMARKERS; DRUG PRODUCTS; MASS SPECTROMETRY;

FLUOROPHORES; LIGANDS;

BIOASSAY;

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; RADIOASSAY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; BINDING, COMPETITIVE; DOPAMINE ANTAGONISTS; MASS SPECTROMETRY; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1;

EID: 0242635999     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200351806     Document Type: Article

References (24)

1. P. M. Sweetnam, C. H. Price, J. W. Ferkany in Burger's Medicinal Chemistrry and Drug Discovery (Ed.: M. E. Wolff), Wiley, New York, 1995, pp. 697-731.
2. M. Williams, M. A. Sills in Comprehensive Medicinal Chemistry, Vol. III (Ed.: J. C. Emmet), Pergamon, Oxford, 1990, pp. 45-79.
3. a) N. Baindur, D. J. Triggle, Med. Res. Rev. 1994, 14, 591-664;
4. b) R. Hovius, P. Vallotton, T. Wohland, H. Vogel, Trends Pharmacol. Sci. 2000, 21, 266-273.
5. J. C. McGrath, S. Arribas, C. J. Daly, Trends Pharmacol. Sci. 1996, 17, 393-399.
6. a) D. B. Kassel, Chem. Rev. 2001, 101, 255-267;
7. b) G. R. Lenz, H. M. Nash, S. Jindal, Drug Discovery Today 2000, 5, 145-156;
8. c) R. D. Süßmuth, G. Jung, J. Chromatogr B 1999, 725, 49-65.
9. a) R. N. Zuckermann, J. M. Kerr, M. A. Siani, S. C. Banville, D. V. Santi, Proc. Natl. Acad. Sci. USA 1992, 89, 4505-4509;
10. b) J. Gao, X. Cheng, R. Chen, G. B. Sigal, J. E. Bruce, B. L. Schwartz, S. A. Hofstadler, G. A. Anderson, R. D. Smith, G. M. Whitesides, J. Med. Chem. 1996, 39, 1949-1955;
11. c) S. Kaur, L. McGuire, D. Tang, G. Dollinger, V. Huebner, J. Protein Chem. 1997, 16, 505-511;
12. d) M. A. Kelly, H. Liang, I. I. Sytwu, I. Vlattas, N. L. Lyons, B. R. Bowen, L. P. Wennogle, Biochemistry 1996, 35, 11 747-11 755;
13. e) D. Nikolic, S. Habibi-Gouarzi, D. G. Corley, S. Gafner, J. M. Pezzuto, R. B. van Breemen, Anal. Chem. 2000, 72, 3853-3859;
14. f) R. Wieboldt, J. Zweigenbaum, J. Henion, Anal. Chem. 1997, 69, 1683-1691;
15. g) D. C. Schriemer, D. R. Bundle, L. Li, O. Hindsgaul, Angew. Chem. 1998, 110, 3625-3628; Angew. Chem. Int. Ed. 1998, 37, 3383-3387;
16. g) D. C. Schriemer, D. R. Bundle, L. Li, O. Hindsgaul, Angew. Chem. 1998, 110, 3625-3628; Angew. Chem. Int. Ed. 1998, 37, 3383-3387;
17. recently related NMR spectroscopic methods were described: h) W. Jahnke, P. Floersheim, C. Ostermeier, X. Zhang, R. Hemming, K. Hurth, D. P. Uzunov, Angew. Chem. 2002, 114, 3570-3573; Angew. Chem. Int. Ed. 2002, 41, 3420-3423;
18. recently related NMR spectroscopic methods were described: h) W. Jahnke, P. Floersheim, C. Ostermeier, X. Zhang, R. Hemming, K. Hurth, D. P. Uzunov, Angew. Chem. 2002, 114, 3570-3573; Angew. Chem. Int. Ed. 2002, 41, 3420-3423;
19. i) A. H. Siriwardena, F. Tian, S. Noble, J. H. Prestegard, Angew. Chem. 2002, 114, 3604-3607; Angew. Chem. Int. Ed. 2002, 41, 3454-3457.
20. i) A. H. Siriwardena, F. Tian, S. Noble, J. H. Prestegard, Angew. Chem. 2002, 114, 3604-3607; Angew. Chem. Int. Ed. 2002, 41, 3454-3457.
21. E. C. Hulme, N. J. Buckley in Receptor-Ligand Interactions (Ed.: E. C. Hulme), Oxford University Press, New York. 1992, pp. 177-212.
22. W. Billard, V. Ruperto, G. Crosby, L. C. Iorio, A. Barnett, Life Sci. 1984, 35, 1885-1893.
23. For experimental details see Supporting Information.
24. D. R. Burt, I. Creese, S. Snyder, Mol. Pharmacol. 1976, 12, 800-812.